166 related articles for article (PubMed ID: 10721786)
1. Plasma erythropoietin concentrations in polycythaemia vera with special reference to myelosuppressive therapy.
Andréasson B; Carneskog J; Lindstedt G; Lundberg PA; Swolin B; Wadenvik H; Kutti J
Leuk Lymphoma; 2000 Mar; 37(1-2):189-95. PubMed ID: 10721786
[TBL] [Abstract][Full Text] [Related]
2. Plasma erythropoietin by high-detectability immunoradiometric assay in untreated and treated patients with polycythaemia vera and essential thrombocythaemia.
Carneskog J; Kutti J; Wadenvik H; Lundberg PA; Lindstedt G
Eur J Haematol; 1998 May; 60(5):278-82. PubMed ID: 9654156
[TBL] [Abstract][Full Text] [Related]
3. The relation between plasma thrombopoietin and erythropoietin concentrations in polycythaemia vera and essential thrombocythaemia.
Andréasson B; Lindstedt G; Stockelberg D; Wadenvik H; Kutti J
Leuk Lymphoma; 2001 May; 41(5-6):579-84. PubMed ID: 11378575
[TBL] [Abstract][Full Text] [Related]
4. Hydroxyurea treatment reduces haematopoietic progenitor growth and CD34 positive cells in polycythaemia vera and essential thrombocythaemia.
Andréasson B; Swolin B; Kutti J
Eur J Haematol; 2000 Mar; 64(3):188-93. PubMed ID: 10997885
[TBL] [Abstract][Full Text] [Related]
5. In vitro culture growth of erythroid progenitors and serum erythropoietin assay in the differential diagnosis of polycythaemia.
Shih LY; Lee CT; See LC; Ou YC; Dunn P; Wang PN; Kuo MC; Wu JH
Eur J Clin Invest; 1998 Jul; 28(7):569-76. PubMed ID: 9726038
[TBL] [Abstract][Full Text] [Related]
6. Hydroxyurea therapy increases plasma erythropoietin in patients with essential thrombocythaemia or polycythaemia vera.
Johansson P; Andréasson B
Clin Lab Haematol; 2006 Aug; 28(4):233-6. PubMed ID: 16898960
[TBL] [Abstract][Full Text] [Related]
7. Plasma erythropoietin in essential thrombocythaemia: at diagnosis and in response to myelosuppressive treatment.
Andréasson B; Lindstedt G; Kutti J
Leuk Lymphoma; 2000 Jun; 38(1-2):113-20. PubMed ID: 10811453
[TBL] [Abstract][Full Text] [Related]
8. Patients with idiopathic myelofibrosis show increased CD34+ cell concentrations in peripheral blood compared to patients with polycythaemia vera and essential thrombocythaemia.
Andréasson B; Swolin B; Kutti J
Eur J Haematol; 2002 Apr; 68(4):189-93. PubMed ID: 12071933
[TBL] [Abstract][Full Text] [Related]
9. Red cell mass, spleen size and plasma erythropoietin in polycythaemia vera and apparent polycythaemia.
Johansson P; Safai-Kutti S; Lindstedt G; Suurküla M; Kutti J
Acta Haematol; 2002; 108(1):1-7. PubMed ID: 12145459
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic options for essential thrombocythemia and polycythemia vera.
Solberg LA
Semin Oncol; 2002 Jun; 29(3 Suppl 10):10-5. PubMed ID: 12096352
[TBL] [Abstract][Full Text] [Related]
11. Survival in a patient with polycythaemia vera for over thirty years: implications for treatment decisions in younger patients.
Samuelsson J
Leuk Lymphoma; 1998 Dec; 32(1-2):195-8. PubMed ID: 10037017
[TBL] [Abstract][Full Text] [Related]
12. Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.
Nand S; Stock W; Godwin J; Fisher SG
Am J Hematol; 1996 May; 52(1):42-6. PubMed ID: 8638610
[TBL] [Abstract][Full Text] [Related]
13. Serum erythropoietin in the diagnosis of polycythaemia and after phlebotomy treatment.
Birgegård G; Wide L
Br J Haematol; 1992 Aug; 81(4):603-6. PubMed ID: 1390249
[TBL] [Abstract][Full Text] [Related]
14. Management of patients with polycythaemia vera: results of a survey among Swedish haematologists.
Andreasson B; Löfvenberg E; Westin J
Eur J Haematol; 2005 Jun; 74(6):489-95. PubMed ID: 15876252
[TBL] [Abstract][Full Text] [Related]
15. Elevated serum erythropoietin in a patient with polycythaemia vera presenting with Budd-Chiari syndrome.
Jones C; Levy Y; Tong AW
BMJ Case Rep; 2014 Dec; 2014():. PubMed ID: 25452296
[TBL] [Abstract][Full Text] [Related]
16. Polycythemia vera: a review.
Golden C
Clin J Oncol Nurs; 2003; 7(5):553-6. PubMed ID: 14603552
[TBL] [Abstract][Full Text] [Related]
17. Oxygen affinity is decreased in patients with polycythaemia vera and essential thrombocythaemia.
Johansson P; Brudin G; Nilsson B; Andréasson B
Scand J Clin Lab Invest; 2004; 64(1):71-5. PubMed ID: 15025431
[TBL] [Abstract][Full Text] [Related]
18. Are current methods of measurement of erythropoietin (EPO) in human plasma or serum adequate for the diagnosis of polycythaemia vera and the assessment of EPO deficiency?
Lindstedt G; Lundberg PA
Scand J Clin Lab Invest; 1998 Oct; 58(6):441-58. PubMed ID: 9832336
[TBL] [Abstract][Full Text] [Related]
19. Polycythemia vera and essential thrombocythemia: 2012 update on diagnosis, risk stratification, and management.
Tefferi A
Am J Hematol; 2012 Mar; 87(3):285-93. PubMed ID: 22331582
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and treatment of polycythemia vera and possible future study designs of the PVSG.
Michiels JJ; Barbui T; Finazzi G; Fuchtman SM; Kutti J; Rain JD; Silver RT; Tefferi A; Thiele J
Leuk Lymphoma; 2000 Jan; 36(3-4):239-53. PubMed ID: 10674896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]